The National Cancer Institute and National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, seek input through May 26 on research priorities for COVID-19 serology testing and related technologies, which are key to understanding immunity and developing vaccines against the virus.

The Paycheck Protection Program and Health Care Enhancement Act provides $306 million to NIH to develop, validate, improve and implement serological testing and associated technologies.

The agency intends to solicit applications for funding to establish Serological Sciences Centers of Excellence and projects to advance research on immune responses to the SARS-CoV-2 virus, including how it relates to cancer patients.

Related News Articles

Headline
The Food and Drug Administration yesterday advised people who get a negative result from an at-home COVID-19 antigen test to test themselves again after…
Headline
The Department of Health and Human Services yesterday released new guidance on ordering, reporting, payment and cost-sharing for the COVID-19 monoclonal…
Headline
The Centers for Disease Control and Prevention today released updated guidance to help people protect themselves and others if they are exposed to, sick or…
#HealthCareInnovation Thursday Blog
Situated in the heart of Westchester County and just outside of New York City, White Plains Hospital was among the first hospitals in New York to face the…
Headline
Hospital leaders from the AHA’s vaccine confidence initiative share tips for building COVID-19 vaccine confidence. “Getting more Americans vaccinated against…
Blog
This is a confusing time in the public health emergency. Americans are thinking less about COVID-19 on a daily basis and many are eager to move on. But COVID-…